Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
ASSETS    
Available-for-sale securities, at fair value (amortized cost $9,497,257 and $8,114,627, respectively; allowance for credit losses $4,556 and $6,958, respectively) $ 8,830,726 $ 7,778,734
Mortgage servicing rights, at fair value 3,213,113 2,984,937
Cash and cash equivalents 644,184 683,479
Restricted cash 400,777 443,026
Accrued interest receivable 39,038 36,018
Due from counterparties 315,467 253,374
Derivative assets, at fair value 20,592 26,438
Reverse repurchase agreements 282,767 1,066,935
Other assets 170,065 193,219
Total Assets 13,916,729 13,466,160
Liabilities    
Repurchase agreements 9,113,270 8,603,011
Revolving credit facilities 1,410,671 1,118,831
Term notes payable 295,025 398,011
Convertible senior notes 268,179 282,496
Derivative liabilities, at fair value 23,550 34,048
Due to counterparties 312,248 541,709
Dividends payable 55,675 64,504
Accrued interest payable 90,709 94,034
Commitments and contingencies (see Note 16) 0 0
Other liabilities 230,174 145,991
Total Liabilities 11,799,501 11,282,635
Stockholders' Equity    
Preferred stock, par value $0.01 per share; 100,000,000 shares authorized and 25,578,232 and 26,092,050 shares issued and outstanding, respectively ($639,456 and $652,301 liquidation preference, respectively) 618,579 630,999
Common stock, par value $0.01 per share; 175,000,000 shares authorized and 96,186,425 and 86,428,845 shares issued and outstanding, respectively 962 864
Additional paid-in capital 5,826,133 5,645,998
Accumulated other comprehensive loss (660,008) (278,711)
Cumulative earnings 1,782,654 1,453,371
Cumulative distributions to stockholders (5,451,092) (5,268,996)
Total Stockholders’ Equity 2,117,228 2,183,525
Total Liabilities and Stockholders’ Equity $ 13,916,729 $ 13,466,160